NC
JNJ icon

NovaPoint Capital’s Johnson & Johnson JNJ Stock Holding History

NovaPoint Capital’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.17M Buy
32,178
+647
+2% +$151K 1.7% 18
2026
Q1 		$7.71M Buy
31,531
+1,082
+4% +$252K 1.93% 17
2025
Q4 		$6.3M Buy
30,449
+926
+3% +$183K 1.62% 22
2025
Q3 		$5.47M Buy
29,523
+2,518
+9% +$431K 1.34% 25
2025
Q2 		$4.12M Buy
27,005
+1,149
+4% +$177K 1.26% 36
2025
Q1 		$4.29M Buy
25,856
+942
+4% +$147K 1.32% 26
2024
Q4 		$3.6M Buy
24,914
+953
+4% +$148K 1.1% 36
2024
Q3 		$3.88M Buy
23,961
+521
+2% +$83K 1.2% 31
2024
Q2 		$3.43M Buy
23,440
+1,670
+8% +$248K 1.16% 34
2024
Q1 		$3.44M Sell
21,770
-1,440
-6% -$229K 1.21% 31
2023
Q4 		$3.64M Sell
23,210
-275
-1% -$42.2K 1.35% 25
2023
Q3 		$3.66M Buy
23,485
+798
+4% +$132K 1.45% 20
2023
Q2 		$3.76M Buy
22,687
+106
+0.5% +$17.1K 1.4% 19
2023
Q1 		$3.5M Buy
22,581
+833
+4% +$135K 1.43% 23
2022
Q4 		$3.84M Buy
21,748
+73
+0.3% +$12.6K 1.68% 13
2022
Q3 		$3.54M Sell
21,675
-142
-0.7% -$24K 1.61% 12
2022
Q2 		$3.87M Buy
21,817
+792
+4% +$141K 1.68% 9
2022
Q1 		$3.73M Buy
21,025
+784
+4% +$133K 1.36% 25
2021
Q4 		$3.46M Buy
20,241
+1,583
+8% +$259K 1.24% 29
2021
Q3 		$3.01M Buy
18,658
+1,357
+8% +$232K 1.21% 29
2021
Q2 		$2.85M Buy
17,301
+513
+3% +$84.9K 1.18% 32
2021
Q1 		$2.76M Buy
16,788
+74
+0.4% +$12K 1.29% 27
2020
Q4 		$2.63M Buy
16,714
+2,020
+14% +$298K 1.37% 25
2020
Q3 		$2.19M Buy
14,694
+622
+4% +$92K 1.42% 21
2020
Q2 		$1.98M Buy
14,072
+528
+4% +$76.9K 1.47% 19
2020
Q1 		$1.78M Sell
13,544
-281
-2% -$39.9K 1.62% 13
2019
Q4 		$2.02M Buy
+13,825
New +$1.88M 1.58% 13

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

NovaPoint Capital's JNJ Position: Q2 2026 in Review

NovaPoint Capital increased its Johnson & Johnson (JNJ) stake by 2.1% in Q2 2026, buying an estimated $151K and bringing the position to 32,178 shares worth $8.17M. The position accounts for 1.7% of the portfolio, ranked #18.

NovaPoint Capital first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • NovaPoint Capital held 32,178 shares of Johnson & Johnson worth $8.17M as of Q2 2026.
  • NovaPoint Capital bought 647 Johnson & Johnson shares in Q2 2026, an estimated $151K.
  • Johnson & Johnson made up 1.7% of NovaPoint Capital's portfolio in Q2 2026, its #18 holding.
  • NovaPoint Capital first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on NovaPoint Capital's 13F filing for Q2 2026, filed 6 Aug 2026.